Skip to main content
v2026.11,986 entries · CC-BY 4.0

Memorandum of Agreement Template for Research Grants

A comprehensive memorandum of agreement template for research grant partnerships, mapping required clauses, federal flow-downs, and approval workflows.

Written and maintained by CASRAI Editorial Board

Published

On this page

A memorandum of agreement (MOA) template for research grants provides a legally binding contractual framework that defines the cooperative scope of work, budget allocations, performance milestones, and regulatory compliance obligations between two or more collaborating institutions. Unlike an exploratory memorandum of understanding, an MOA establishes enforceable operational commitments governed by institutional research offices and federal pass-through requirements under Uniform Guidance 2 CFR 200.

Ask CASRAI · free to tryQuestion about this guide? Ask CASRAI answers with linked sources. 2 free questions a day, no account.

Ask your first question freeSubscribe

What it is and who runs it

In academic research administration and sponsored program management, a Memorandum of Agreement (MOA) serves as a formal, legally enforceable document executed between distinct legal entities to govern collaborative research, shared facilities, or pass-through grant activities. While cross-institutional scientific collaborations often originate through informal discussions between Principal Investigators (PIs), the formal operationalization of any project involving dedicated personnel time, institutional resources, data exchange, or sponsored funds requires a legally ratified contract. The MOA defines exactly what each participating institution agrees to execute, the precise financial consideration or resource commitment involved, intellectual property ownership boundaries, and the dispute mechanisms that govern the project throughout its lifecycle.

Operationally, an MOA is drafted, negotiated, and administered by institutional central research administration bodies rather than individual laboratory staff. Within higher education and independent research organizations, this oversight is conducted through the Office of Sponsored Programs (OSP), the Office of Research Administration (ORA), or sponsored contracts divisions. In federal and state government bodies, such agreements are administered by designated Grants Management Specialists (GMS), Contracting Officers (CO), or Inter-Agency Agreement liaisons. When a project involves complex federal funding, research administrators align the instrument with our comparison of MOA and MOU frameworks to verify whether a binding agreement or a non-binding intent document fits the intended collaboration.

Institutional research administration offices enforce strict statutory and fiduciary standards when establishing an MOA. As described on the official page on 2026-11-15 for federal grants governance, awards issued by agencies such as the National Institutes of Health (NIH), the National Science Foundation (NSF), and the Department of Energy (DOE) mandate that prime recipients maintain documented oversight of all collaborating organizations. The institutional signatories—specifically Authorized Organizational Representatives (AORs)—assume legal liability on behalf of the board of regents or corporate trustees, ensuring that technical deliverables match sponsor expectations and that public funds comply with cost-accounting standards.

Eligibility (summary, with the official source)

Entering into a formal research Memorandum of Agreement requires distinct institutional eligibility, legal capacity, and delegated signatory authority. Because an MOA creates binding contractual commitments, legal eligibility resides exclusively with recognized legal entities rather than individual investigators, academic departments, or student researchers. According to the Electronic Code of Federal Regulations (eCFR) governing federal assistance at 2 CFR 200.331 and 2 CFR 200.332, eligible participating organizations in research collaborations include:

  • Accredited Institutions of Higher Education (IHEs): Public universities, state university systems, and private non-profit colleges registered in the federal System for Award Management (SAM.gov) with an active Unique Entity Identifier (UEI).
  • Non-Profit Research Institutes and Academic Medical Centers: 501(c)(3) healthcare systems, biomedical institutes, and independent laboratories possessing established financial accounting systems capable of single audits under Uniform Guidance Subpart F.
  • State, Local, and Tribal Government Entities: Public health departments, municipal authorities, and tribal organizations collaborating on sponsored field studies or community-engaged interventions.
  • Commercial and Industrial Partners: For-profit corporations, small businesses (including SBIR/STTR awardees), and industrial consortia participating in applied research or technology development under negotiated cost-sharing terms.
  • Federal Laboratories and Agencies: Federal research facilities executing intra-governmental or inter-agency agreements under statutory authorities such as the Economy Act (31 U.S.C. 1535).

A foundational legal tenet across university research administration is the clear distinction between scientific eligibility and institutional execution authority. While a Principal Investigator holds scientific eligibility to propose the statement of work, draft technical milestones, and oversee daily experimental protocols, PIs do not possess the legal power to execute an MOA. As maintained across university sponsored research policies (including Johns Hopkins University ORA, University of California, and NC State University contracting offices), only an appointed Authorized Organizational Representative (AOR)—such as the Vice President for Research, Assistant Vice Chancellor for Research, or Director of Sponsored Programs—holds delegated authority from the governing board to sign binding agreements. An MOA executed solely by a PI or department chair is legally ultra vires and unenforceable against the institution.

What it funds or requires

A research Memorandum of Agreement establishes the enforceable operational architecture of a collaborative project. Depending on whether the instrument functions as an inter-institutional collaboration, a pass-through subaward, or a cost-sharing partnership, the MOA requires comprehensive technical, fiscal, and regulatory clauses. Research projects commonly navigate distinct funding structures, requiring administrators to evaluate grants, contracts, and cooperative agreements to determine the precise terms that must be incorporated into the agreement.

Core Contractual Clauses in an MOA Template

A standard academic and grant-funded research MOA template incorporates eleven core operational articles, structured as follows:

  • Preamble and Identification of Parties: Formally names the collaborating legal entities, principal business addresses, and respective institutional types (e.g., “The Board of Regents of the University of [State], on behalf of its Department of Chemistry, and [Collaborator Medical Center], a non-profit healthcare system”).
  • Recitals and Grant Context: Identifies the overarching funding source, citing the prime award sponsor (e.g., NIH, NSF, DOD), Federal Award Identification Number (FAIN), prime project title, and designated Assistance Listings Number.
  • Statement of Work (SOW): Formulates the technical responsibilities, specific experimental tasks, sampling protocols, and analytical workflows assigned to each institution, attached as an enforceable exhibit (Attachment A).
  • Period of Performance: Specifies the exact effective start date and expiration date, tying continuation to prime sponsor budget periods and renewal options.
  • Financial Consideration and Payment Schedule: Establishes the total obligated budget ceiling, approved cost categories, invoicing frequency (typically monthly or quarterly cost-reimbursement), allowable indirect cost rates, and payment terms (such as net 30 days upon receipt of an itemized invoice).
  • Key Personnel and Effort Commitments: Designates named investigators (Lead PI, Co-PIs, Project Directors) and outlines mandatory notification procedures if named personnel disengage, reduce effort by more than 25 percent, or change institutional affiliation.
  • Intellectual Property and Invention Rights: Establishes ownership rights, preserving background intellectual property (pre-existing patents, know-how, and proprietary data) while establishing clear protocols for sole or joint inventorship of foreground technology under the federal Bayh-Dole Act (35 U.S.C. 200-212).
  • Publication and Academic Freedom: Safeguards academic researchers’ right to publish scientific findings, while establishing a reasonable pre-publication review window (typically 30 to 60 days) enabling collaborating parties to screen manuscripts for proprietary data or patentable subject matter.
  • Data Sharing, Record Retention, and Audit Access: Formulates data management protocols in compliance with sponsor directives. Under the updated NIH Grants Policy Statement Section 15.2 and NIH Notice NOT-OD-23-182, foreign and domestic subrecipients must grant the prime recipient and federal auditors access to all underlying research documentation, raw data, and laboratory notebooks supporting progress reports at least annually.
  • Regulatory Assurances and Compliance: Mandates active approval notices from institutional oversight boards prior to initiating regulated activities, including Institutional Review Board (IRB) approval for human subjects research under 45 CFR 46, Institutional Animal Care and Use Committee (IACUC) approval for vertebrate animal protocols under 9 CFR, and export control reviews (ITAR/EAR).
  • Termination, Suspension, and Remedies: Establishes unilateral and bilateral termination terms, distinguishing termination for cause (such as material breach or loss of regulatory approval) from termination for convenience (such as sponsor withdrawal of funds), accompanied by mandatory 30-day written notice and reimbursement for non-cancelable obligations.

Budget Breakdown and Cost Principles

The financial exhibits attached to an MOA template must categorize expenditures in strict alignment with federal cost principles outlined in 2 CFR 200 Subpart E. Collaborating organizations must delineate their financial allocations into direct personnel costs, laboratory consumables, specialized equipment, travel, and facility charges, observing the regulatory boundary between direct versus indirect costs. When establishing indirect cost recovery in an MOA, prime institutions must honor the collaborating entity’s federally negotiated indirect cost rate agreement (NICRA); if the collaborator has never negotiated a federal rate, 2 CFR 200.414 permits the application of the standard 10 percent de minimis modified total direct cost (MTDC) rate.

Worked Illustrative Template Structure

The following composite model illustrates the standard clause structure and operational language utilized by university sponsored research offices when drafting an inter-institutional research MOA:

MEMORANDUM OF AGREEMENT FOR COLLABORATIVE RESEARCH
BETWEEN [PRIME RECIPIENT INSTITUTION] AND [COLLABORATING INSTITUTION]

ARTICLE I: PARTIES AND PURPOSE
This Memorandum of Agreement ("MOA") is entered into by and between [Prime Institution], 
having its principal office at [Address], and [Collaborating Institution], having its 
principal office at [Address] (collectively, the "Parties"). This MOA governs collaborative 
performance under [Prime Sponsor] Award No. [FAIN] entitled "[Project Title]".

ARTICLE II: STATEMENT OF WORK
Collaborator agrees to perform the research tasks described in Attachment A ("Statement 
of Work"), under the technical direction of Dr. [Collaborator Lead Investigator], in 
close collaboration with Dr. [Prime Lead Investigator].

ARTICLE III: PERIOD OF PERFORMANCE
The period of performance shall commence on [Start Date] and conclude on [End Date], 
co-terminus with Prime Award Budget Period [Number], unless extended by mutual written amendment.

ARTICLE IV: FINANCIAL CONSIDERATION AND BILLING
Prime Institution shall reimburse Collaborator for actual, allowable, and allocable 
costs incurred up to an aggregate maximum of $[Total Budget], as detailed in Attachment B. 
Collaborator shall submit monthly invoices detailing direct personnel, supplies, and 
applicable F&A costs calculated at Collaborator's federally approved rate of [X]%. 
Invoices shall be payable within thirty (30) days of receipt and approval.

ARTICLE V: REPORTING AND ACCESS TO DATA
Collaborator shall submit quarterly technical progress reports fifteen (15) days prior 
to Prime Institution's federal reporting deadlines. Pursuant to NIH GPS 15.2, Collaborator 
agrees to provide Prime Institution electronic access to all primary research data, 
laboratory records, and analysis files supporting reported outcomes at least annually.

ARTICLE VI: REGULATORY COMPLIANCE
No human subjects or animal protocols shall be performed without active IRB (Federalwide 
Assurance #[FWA]) or IACUC approval. The Parties shall maintain compliance with federal 
Financial Conflict of Interest (FCOI) regulations under 42 CFR Part 50 Subpart F.

ARTICLE VII: INTELLECTUAL PROPERTY AND PUBLICATION
Each Party retains ownership of its Background IP. Foreground inventions conceived solely 
by one Party shall belong to that Party; inventions conceived jointly shall be jointly owned. 
Either Party may publish collaborative results, subject to providing thirty (30) days 
prior written notice for patent review and removal of confidential information.

ARTICLE VIII: TERMINATION
Either Party may terminate this MOA without cause upon sixty (60) days advance written 
notice. Upon receipt of notice, Collaborator shall cease all further commitments and 
submit a final invoice for allowable incurred costs and non-cancelable obligations.

IN WITNESS WHEREOF, the Parties have caused this MOA to be executed by their Authorized 
Organizational Representatives:

For [Prime Institution]:                     For [Collaborating Institution]:
_______________________________             _______________________________
[Name, Title of AOR]                        [Name, Title of AOR]
Date: _________________________             Date: _________________________

Application or compliance steps

Developing, negotiating, and formalizing a research Memorandum of Agreement follows a structured institutional lifecycle. To ensure contractual integrity, protect research compliance, and prevent audit disallowances, institutions execute six sequential operational steps:

Step 1: Collaborative Scope and Statement of Work Formulation

The collaborating Principal Investigators define the technical objectives, specific research divisions, shared facilities, and expected scientific deliverables. The technical narrative must detail which institution will generate primary data, where biological or physical samples will be stored, and who will oversee specific analytical models. This Statement of Work (SOW) serves as Attachment A of the MOA and must avoid vague aspirational language, substituting specific measurable milestones.

Step 2: Subrecipient versus Contractor Triage and Budget Justification

Prior to drafting the agreement, the prime institution’s research office performs an official entity classification under 2 CFR 200.331. The office determines whether the collaborating organization acts as a subrecipient (carrying program responsibility, participating in intellectual design, and measured against federal performance goals) or a commercial contractor (providing routine procurement services or standardized testing in a competitive market). If classified as a subrecipient, a detailed line-item budget and justification are established as Attachment B, confirming applicable indirect cost rates and fringe benefit schedules.

Step 3: Subrecipient Risk Assessment and Compliance Screening

The prime institution conducts mandatory pre-award risk screening on the collaborating organization. Under federal Uniform Guidance mandates, the sponsored programs office reviews the partner’s most recent Single Audit (formerly A-133), checks the federal System for Award Management (SAM.gov) for active exclusions or debarments, verifies active Federalwide Assurance (FWA) numbers for human subjects research, and confirms institutional Financial Conflict of Interest (FCOI) policies compliant with 42 CFR 50.

The draft MOA is routed through the central sponsored research contracting office. Research contract officers review the legal terms against university policy guidelines, state constitutional restrictions (such as prohibitions against indemnification for state public universities), and federal pass-through mandates. If intellectual property or commercial licensing considerations arise, the university technology transfer office participates in clause negotiation to preserve commercialization pathways.

Step 5: Bilateral Institutional Execution by AORs

Once terms are mutually settled, the MOA is routed for formal execution through secure enterprise contract management platforms (such as Cayuse, Kuali, or DocuSign). The Authorized Organizational Representative from each institution signs the agreement. Principal Investigators frequently sign an internal institutional acknowledgment page certifying their understanding of technical and reporting obligations, but the legal contract remains strictly between the institutional corporate bodies.

Step 6: Account Establishment, Encumbrance, and Post-Award Monitoring

Following bilateral signature, the prime research office activates a dedicated internal subaccount (or purchase order encumbrance) linked to the prime grant. Throughout the project lifecycle, the prime institution tracks quarterly technical milestones, reconciles monthly expenditure invoices against allowable budget lines, monitors annual record turnover, and conducts closeout audits within 90 days of project conclusion.

Typical timeline phases (no calendar dates as facts)

The operational lifecycle of a research Memorandum of Agreement spans five distinct operational phases. The duration of each phase depends on the complexity of the research protocol, the risk profile of the collaborating organization, and whether specialized compliance authorizations are required:

  • Phase 1: Pre-Proposal Collaboration and Letter of Intent (4 to 8 Weeks Prior to Grant Submission): During the grant proposal stage, collaborating investigators develop preliminary task allocations, obtain institutional letters of intent signed by the partner’s AOR, and construct the proposed collaborative budget and justification.
  • Phase 2: Post-Award Review and Formal Drafting (2 to 4 Weeks Post Prime Notice of Award): Upon receiving the formal Notice of Award (NOA) from the prime sponsor, the prime institution’s sponsored programs office initiates the MOA drafting process, converting the proposal work plan into binding contractual exhibits.
  • Phase 3: Institutional Negotiation and Legal Refinement (3 to 6 Weeks): Contract officers from both institutions review liability, publication notice windows, intellectual property clauses, and data access protocols. For agreements involving international entities or sensitive clinical data, review cycles may extend while custom compliance provisions are negotiated.
  • Phase 4: Bilateral Execution and Financial Setup (1 to 2 Weeks): The agreement is signed by both institutional AORs, the prime institution encumbers the obligated funds, and the collaborator establishes a restricted research ledger to capture project-specific costs.
  • Phase 5: Performance Oversight and Reconciliation (Ongoing Throughout Performance Period): Collaborating teams execute experimental tasks, submit regular technical progress updates, invoice monthly or quarterly, and complete annual scientific documentation exchanges.
  • Phase 6: Closeout and Technical Reconciliation (0 to 90 Days Post-Expiration): Final scientific deliverables are submitted, final financial reconciliation occurs, property and equipment inventories are logged, and final closeout releases are executed.

Common mistakes

Research administrators, department administrators, and investigators frequently encounter avoidable compliance hazards when executing collaboration agreements. The most frequent errors include:

  • Confusing an MOA with a Non-Binding MOU: Treating an agreement containing financial commitments or intellectual property assignments as an informal memorandum of understanding. If an instrument commits resources, establishes liability, or mandates specific scientific deliverables, it must be drafted and approved as a binding MOA rather than an aspirational memorandum of understanding template.
  • Unauthorized Signatures by Principal Investigators: Permitting a faculty member, laboratory director, or department chair to execute an MOA with an external entity. University charters reserve contract-signing authority exclusively for designated corporate officers and AORs; unauthorized signatures invalidate institutional insurance coverage and create personal legal exposure for the investigator.
  • Omitting Mandatory Federal Flow-Down Provisions: Failing to incorporate compulsory federal requirements under 2 CFR 200.332, such as the Federal Award Identification Number (FAIN), Unique Entity Identifier (UEI), Single Audit requirements, and federal non-discrimination mandates. Incomplete subrecipient agreements can result in federal audit findings and questioned costs during institutional compliance reviews.
  • Overly Restrictive or Missing Publication Clauses: Agreeing to external partner terms that allow an industry sponsor or collaborator to censor or indefinitely delay scientific publications. Academic institutional policies mandate that pre-publication review be strictly limited to a defined window (such as 30 to 60 days) solely to protect proprietary confidential information and preserve patent filing opportunities.
  • Vague Statements of Work and Ambiguous Deliverables: Drafting technical scopes that outline broad research aspirations rather than measurable deliverables and performance milestones. When deliverables are poorly defined, prime institutions lose the contractual ability to withhold invoice payments or enforce remedies for non-performance.
  • Inadequate Cost-Sharing Commitments: Promising institutional cost-matching or contributed faculty effort within an MOA without securing prior written authorization from institutional financial leadership and deans.

In academic research contracting, an MOA is one of several specialized instruments designed to formalize relationships between institutions, industry sponsors, and government agencies. Selecting the correct instrument depends on whether funds are transferred, whether intellectual property is licensed, and the level of legal enforceability required by the parties. The data table below compares the primary institutional collaboration instruments utilized across university sponsored research offices.

Agreement Instrument Primary Purpose Funding Transfer Legal Status Governing Framework
Memorandum of Agreement (MOA) Binding cooperative research with committed resources and deliverables Yes (direct or cost-share) Legally Enforceable Uniform Guidance 2 CFR 200
Memorandum of Understanding (MOU) Non-binding institutional framework exploring joint collaboration No (separate contract needed) Aspirational / Non-enforceable Institutional Governance
Sponsored Research Agreement (SRA) Direct funding from corporate or private sponsor for directed research Yes (full project funding) Legally Enforceable Commercial Contract Law / OSP
Inter-Agency Agreement (IAA) Inter-governmental resource or service exchange between public agencies Yes (reimbursement / advance) Legally Enforceable 31 U.S.C. 1535 (Economy Act)
Data Use Agreement (DUA) Establishes access, security, and usage boundaries for sensitive datasets No (data access governance) Legally Enforceable HIPAA / Institutional IRB
Material Transfer Agreement (MTA) Governs physical transfer of biological samples, reagents, or cell lines No (material exchange only) Legally Enforceable Uniform Biological MTA (UBMTA)

Frequently asked questions

What is the fundamental difference between an MOA and an MOU in research?

The primary difference lies in legal enforceability and resource commitments. A Memorandum of Understanding (MOU) is typically an aspirational, non-binding statement of mutual intent outlining how institutions plan to explore partnership opportunities without creating financial obligations. In contrast, a Memorandum of Agreement (MOA) is a legally binding contract that establishes specific operational duties, resource allocations, intellectual property terms, performance milestones, and regulatory compliance requirements between the participating organizations.

Can a Principal Investigator sign a Memorandum of Agreement on behalf of their university?

No. While Principal Investigators lead the scientific execution and design the statement of work, university governing boards reserve contract execution authority exclusively for designated Authorized Organizational Representatives (AORs). Signature authority is delegated to institutional officers such as the Vice President for Research, Director of Sponsored Programs, or authorized contracting officers. Contracts signed solely by a PI or department chair are legally invalid and do not bind the university.

Is a Memorandum of Agreement required for NIH or NSF grant subawards?

Yes. Under federal Uniform Guidance (2 CFR 200.332) and Section 15.2 of the NIH Grants Policy Statement, prime recipients are legally mandated to execute formal bilateral written agreements with all subrecipients. These written agreements—often designated as subaward agreements or collaborative MOAs—must incorporate federal award identifiers, pass-through statutory compliance provisions, budget parameters, and explicit audit access terms prior to initiating subaward activities.

What federal clauses must flow down into an MOA under 2 CFR 200?

Under 2 CFR 200.332, pass-through entities must include federal award identification details (such as the subrecipient name, Unique Entity Identifier, Federal Award Identification Number, and federal award date), mandatory flow-down statutory requirements (such as Title VI non-discrimination and drug-free workplace rules), financial and technical progress reporting schedules, subrecipient monitoring protocols, and explicit clauses granting the prime recipient and federal auditors full access to records.

How should intellectual property and publication rights be handled in an MOA?

A properly structured research MOA follows the framework of the federal Bayh-Dole Act. Each party maintains sole ownership of its pre-existing background intellectual property. Foreground inventions conceived solely by one party belong to that party, while inventions developed jointly are co-owned. Publication clauses must protect the academic freedom of researchers to publish findings without undue delay, while providing collaborating partners a reasonable review window of 30 to 60 days to identify patentable material and redact proprietary information.

What happens if a collaborating party fails to meet deliverables in an MOA?

Because an MOA is a legally binding agreement, non-performance constitutes a contractual breach. Standard MOA templates incorporate progressive remedies, beginning with formal written notice and a 30-day cure period. If the collaborating institution fails to remedy the deficiency or provide acceptable deliverables, the prime institution may suspend further funding disbursements, invoke termination for cause, and recover unexpended advance funds or seek formal dispute resolution as provided in the agreement.

Sources

  • Electronic Code of Federal Regulations (eCFR). Title 2, Subtitle A, Chapter II, Part 200 – Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (2 CFR 200.331 and 200.332). URL: https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200. Accessed: 2026-11-15.
  • National Institutes of Health (NIH). NIH Grants Policy Statement (NIHGPS), Section 15: Consortium Agreements, Subsection 15.2: Administrative and Other Requirements. URL: https://grants.nih.gov/grants/policy/nihgps/HTML5/section_15/15.2_administrative_and_other_requirements.htm. Accessed: 2026-11-15.
  • Substance Abuse and Mental Health Services Administration (SAMHSA). Prevention Collaboration in Action Toolkit: Creating a Memorandum of Agreement. URL: https://www.samhsa.gov/. Accessed: 2026-11-15.
  • U.S. Department of Justice (DOJ), Office of Justice Programs (OJP). Financial Guide: Inter-Organizational Collaboration and Memorandum of Agreement Guidelines. URL: https://www.ojp.gov/funding/financial-guided-grantee/part-iii-postaward-requirements. Accessed: 2026-11-15.
  • Johns Hopkins University Research Administration (JHURA) / School of Medicine Office of Research Administration (ORA). Institutional Contracting and Memorandum of Agreement Guidelines. URL: https://www.hopkinsmedicine.org/research/resources/offices-policies/ora/. Accessed: 2026-11-15.
  • National Science Foundation (NSF). Proposal & Award Policies & Procedures Guide (PAPPG), NSF 24-1: Collaborative Proposals and Subrecipient Administration. URL: https://new.nsf.gov/policies/pappg. Accessed: 2026-11-15.

Data: Research Collaboration and Grant Agreement Instruments Comparison Matrix

Comparative matrix of institutional agreement instruments across legal enforceability, fund obligation authority, 2 CFR 200 federal flow-down obligations, and required signatory authority, compiled from federal Uniform Guidance and university research administration policies.

Period covered: 2024/2026. Coverage: United States.

Research Collaboration and Grant Agreement Instruments Comparison Matrix
Agreement InstrumentPrimary Governing StandardLegal EnforceabilityDirect Fund Obligation PermittedMandatory 2 CFR 200 Flow-DownRequired Executing Signatory
Memorandum of Agreement (MOA)2 CFR 200.332 and Uniform GuidanceBinding contract upon bilateral executionYes (contingent on prime award allocation)Yes (subrecipient flow-down mandates apply)Authorized Organizational Representative (AOR)
Memorandum of Understanding (MOU)University Research Administration PoliciesNon-binding statement of intentNo (requires separate subaward or MOA)No (unless incorporated into binding instrument)Institutional Official or Dean / Department Chair
Federal Subaward Agreement2 CFR 200.331-332 and NIHGPS Section 15Binding legal pass-through agreementYes (obligates federal pass-through funding)Yes (full statutory and regulatory flow-down)Sponsored Programs Authorized Signatory
Inter-Agency Agreement (IAA)31 U.S.C. 1535 (Economy Act) and Federal FARBinding inter-governmental agreementYes (reimbursement or advance between agencies)Yes (federal acquisition and grant rules)Designated Federal Contracting / Grant Officer
Data Use Agreement (DUA)45 CFR 164.514(e) HIPAA / Institutional Data GovernanceBinding institutional data contractNo (governs data access and security only)No (governs privacy, security, and breach terms)Research Compliance / Sponsored Programs Official

Sources

Compiled by CASRAI from the sources above. Free to reuse under CC BY 4.0 with attribution.

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · free to try

Ask about Memorandum of Agreement Template for Research Grants

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →